Relationship between hepatitis C virus recurrence and de novo diabetes after liver transplantation: The Hungarian experience

Transplantation Proceedings

Volumn 43, Issue 4, 2011, Pages 1281-1282

  Gelley, F ^a   Zadori, G ^a   Firneisz, G ^a   Wagner, L ^a   Fehervari I ^a   Gerlei, Z ^a   Fazakas, J ^a   Papai, S ^a   Lengyel, G ^a   Sarvary, E ^a   Nemes, B ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEGINTERFERON; RIBAVIRIN;

ANTIVIRAL THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EXPERIENCE; FIBROSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUNGARY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; VIREMIA;

ANTIVIRAL AGENTS; DIABETES MELLITUS; HEPATITIS C; HUMANS; HUNGARY; HYPOGLYCEMIC AGENTS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VIREMIA;

EID: 79957598049     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.03.065     Document Type: Conference Paper

References (12)

1. Khalili M, Lim JW, Bass N, et al: New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transplantation 10:349, 2004
2. Davidson JA, Wilkinson A: New-onset diabetes after transplantation 2003 International Consensus Guidelines: an endocrinologist's view. Diabetes Care 27:805, 2004
3. Nemes B, Doros A, Holczbauer A, et al: Expression pattern of molecular chaperones after liver transplantation in hepatitis C positive patients. Relation to serum HCV-RNA titers. Intervent Med Appl Sci 1:35, 2009
4. Nemes B, Sárváry E, Kóbori L, et al: Serum hepatitis C virus-ribonucleotide acid monitoring after liver transplantation: the Hungarian experience. Dig Liv Dis 37:68, 2005
5. Shah A, Kendall G, Demme RA, et al: Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation 80:775, 2005
6. Delgado-Borrego A, Liu YS, Jordan SH, et al: Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance. Liver Transpl 14:193, 2008
7. Aytug S, Reich D, Sapiro LE, et al: Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 38:1384, 2003
8. Kawaguchi T, Yoshida T, Harada M, et al: Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through upregulation of suppressor of cytokine signaling 3. Am J Pathol 165:1499, 2004
9. Hung CH, Wang JH, Hu TH, et al: Insuline resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World J Gastroenterol 16:2265, 2010
10. Romero-Gomez M: Hepatitis C and insulin resistance: steatosis, fibrosis and non-response. Rev Esp Enferm Dig 98:8:605, 2006
11. Paradis V, Perlemuter G, Bonvoust F, et al: High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 34:738, 2001
12. Romero-Gomez M, Del Mar Viloria M, Andrade RJ, et al: Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128:636, 2005